Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging


Ischaemic heart disease evokes a complex immune response. However, tools to track the systemic behaviour and dynamics of leukocytes non-invasively in vivo are lacking. Here, we present a multimodal hot-spot imaging approach using an innovative high-density lipoprotein-derived nanotracer with a perfluoro-crown ether payload (19F-HDL) to allow myeloid cell tracking by 19F magnetic resonance imaging. The 19F-HDL nanotracer can additionally be labelled with zirconium-89 and fluorophores to detect myeloid cells by in vivo positron emission tomography imaging and optical modalities, respectively. Using our nanotracer in atherosclerotic mice with myocardial infarction, we observed rapid myeloid cell egress from the spleen and bone marrow by in vivo 19F-HDL magnetic resonance imaging. Concurrently, using ex vivo techniques, we showed that circulating pro-inflammatory myeloid cells accumulated in atherosclerotic plaques and at the myocardial infarct site. Our multimodality imaging approach is a valuable addition to the immunology toolbox, enabling the study of complex myeloid cell behaviour dynamically.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Nanotracer platform with multimodal evaluation in ischaemic heart disease.
Fig. 2: Developing and characterizing multimodal nanotracers.
Fig. 3: Characterization in atherosclerosis.
Fig. 4: Longitudinal evaluation of myeloid cell dynamics during atherosclerosis development.
Fig. 5: Multimodal imaging of myeloid cell egress from haematopoietic organs and recruitment to inflammatory sites in MI.

Data availability

The data that support the plots within this paper and other findings of this study are available from the corresponding author upon reasonable request.


  1. 1.

    Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341–355 (2011).

    CAS  Article  Google Scholar 

  2. 2.

    Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013).

    CAS  Article  Google Scholar 

  3. 3.

    Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661 (2010).

    CAS  Article  Google Scholar 

  4. 4.

    Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161–166 (2013).

    CAS  Article  Google Scholar 

  5. 5.

    Dutta, P. et al. Myocardial infarction accelerates atherosclerosis. Nature 487, 325–329 (2012).

    CAS  Article  Google Scholar 

  6. 6.

    Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

    CAS  Article  Google Scholar 

  7. 7.

    Nahrendorf, M. Myeloid cell contributions to cardiovascular health and disease. Nat. Med. 24, 711–720 (2018).

    CAS  Article  Google Scholar 

  8. 8.

    Herisson, F. et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat. Neurosci. 21, 1209–1217 (2018).

    CAS  Article  Google Scholar 

  9. 9.

    Swirski, F. K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612–616 (2009).

    CAS  Article  Google Scholar 

  10. 10.

    Tawakol, A. et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389, 834–845 (2017).

    Article  Google Scholar 

  11. 11.

    Thackeray, J. T. et al. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J. Am. Coll. Cardiol. 71, 263–275 (2018).

    CAS  Article  Google Scholar 

  12. 12.

    Heidt, T. et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754–758 (2014).

    CAS  Article  Google Scholar 

  13. 13.

    Roth, S. et al. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke. Sci. Transl. Med. 10, eaao1313 (2018).

    Article  Google Scholar 

  14. 14.

    Pérez-Medina, C. et al. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J. Nucl. Med. 55, 1706–1711 (2014).

    Article  Google Scholar 

  15. 15.

    Tang, J. et al. Immune cell screening of a nanoparticle library improves atherosclerosis therapy. Proc. Natl Acad. Sci. USA 113, E6731–E6740 (2016).

    CAS  Article  Google Scholar 

  16. 16.

    Pérez-Medina, C. et al. In vivo PET imaging of HDL in multiple atherosclerosis models. JACC Cardiovasc. Imaging 9, 950–961 (2016).

    Article  Google Scholar 

  17. 17.

    Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. & Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14, 133–140 (1994).

    CAS  Article  Google Scholar 

  18. 18.

    Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195–205 (2007).

    CAS  Article  Google Scholar 

  19. 19.

    Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166–1172 (2013).

    CAS  Article  Google Scholar 

  20. 20.

    Panizzi, P. et al. Impaired infarct healing in atherosclerotic mice with Ly-6Chi monocytosis. J. Am. Coll. Cardiol. 55, 1629–1638 (2010).

    Article  Google Scholar 

  21. 21.

    von Elverfeldt, D. et al. Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging. Circulation 130, 676–687 (2014).

    CAS  Article  Google Scholar 

  22. 22.

    Heusch, G. et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383, 1933–1943 (2014).

    Article  Google Scholar 

  23. 23.

    Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159–175 (2013).

    CAS  Article  Google Scholar 

  24. 24.

    Soehnlein, O. Multiple roles for neutrophils in atherosclerosis. Circ. Res. 110, 875–888 (2012).

    CAS  Article  Google Scholar 

  25. 25.

    Holland, J. P., Sheh, Y. & Lewis, J. S. Standardized methods for the production of high specific-activity zirconium-89. Nucl. Med. Biol. 36, 729–739 (2009).

    CAS  Article  Google Scholar 

  26. 26.

    Plump, A. S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).

    CAS  Article  Google Scholar 

  27. 27.

    Tarnavski, O. et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol. Genomics 16, 349–360 (2004).

    CAS  Article  Google Scholar 

Download references


This work was supported by De Drie Lichten Foundation in the Netherlands (M.L.S.); American Heart Association grant nos. 17PRE33660729 (M.L.S.) and 16SDG3139000 (C.P.M.); German Research Foundation grant nos. MA 7059/1 (A.M.) and HO 5953/1-1 (M.N.); National Heart, Lung, and Blood Institute grant nos. HL096576, HL117829, HL139598 and HL128264; the MGH Research Scholar Award (M.N. and F.K.S.); Dutch Applied and Engineering Sciences (TTW) grant no. 14716 (G.J.S); National Institutes of Health (NIH) grants: R01HL143814, R01HL144072, R01HL135878 and P01HL131478 (Z.A.F.); R01HL144072, R01CA220234 and P01HL131478 (W.J.M.M.); and the Netherlands Organisation for Scientific Research (NWO) grants: Vidi 91713324 and Vici 91818622 (W.J.M.M.).

Author information




M.L.S. coordinated the experimental planning and execution. W.J.M.M. conceptualized and designed the study. A.J.P.T., B.L.S.-G., C.P.-M. and E.D.K. developed, synthesized, characterized and labelled the nanotracers. M.L.S., A.E.M., M.M.T.L., J.C.V., Y.C.T., A.M., E.D.K., N.A.T.S., A.M.S., H.G., C.F., R.S.O., E.M.L., F.F. and E.C. conducted the in vivo experiments. C.C., Z.A.F. and G.J.S. developed the imaging protocols. M.N. and F.K.S. developed the flow cytometry protocols and provided immunological insights. R.M.D., R.D. and L.Z. contributed expertise on cardiovascular disease mouse models. S.H. and T.R. designed nanotracer labelling strategies. M.L.S. and W.J.M.M. wrote the manuscript and M.L.S. produced the figures for initial submission. All authors reviewed and edited the manuscript before submission.

Corresponding author

Correspondence to Willem J. M. Mulder.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Nanotechnology thanks Jeff Bulte, Christian Schulz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Senders, M.L., Meerwaldt, A.E., van Leent, M.M.T. et al. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging. Nat. Nanotechnol. 15, 398–405 (2020).

Download citation

Further reading


Quick links

Find nanotechnology articles, nanomaterial data and patents all in one place. Visit Nano by Nature Research